Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
0.1400
-0.0099 (-6.60%)
At close: Aug 14, 2026, 4:00 PM EDT
0.132309
-0.0077 (-5.49%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $6.28 million as of August 14, 2026. Its market cap has decreased by -94.51% in one year.
Market Cap
6.28M
Enterprise Value
5.82M
1-Year Change
-94.51%
Ranking
Category
Stock Price
$0.14
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $6.28M, a decrease of -98.18%. That is a compound annual growth rate of -53.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 6.28M | -61.94% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 7.12M |
| Ernexa Therapeutics | 7.02M |
| Alzamend Neuro | 7.00M |
| Processa Pharmaceuticals | 6.88M |
| Niki BioSolutions | 6.82M |
| Evogene | 6.68M |
| Imunon | 6.64M |
| XTL Biopharmaceuticals | 6.59M |